CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)
CUSIP: 18914F103
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 416,598,522
- Total 13F shares
- 146,128,655
- Share change
- +40,208,551
- Total reported value
- $407,670,376
- Put/Call ratio
- 61%
- Price per share
- $2.79
- Number of holders
- 197
- Value change
- +$107,801,104
- Number of buys
- 118
- Number of sells
- 85
Quarterly Holders Quick Answers
What is CUSIP 18914F103?
CUSIP 18914F103 identifies CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 18914F103:
Top shareholders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
|
Company |
7.2%
|
29,813,646
|
$83,180,072 | $0 | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.9%
|
20,580,117
|
$73,882,620 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.6%
|
11,024,400
|
$39,577,596 | — | 31 Mar 2025 | |
| Chamath Palihapitiya |
3/4/5
|
FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner |
—
class O/S missing
|
30,147,610
|
$29,544,657 | — | 07 Jul 2021 | |
| GREENOAKS CAPITAL PARTNERS LLC |
3/4/5
|
Other*, 10%+ Owner |
—
class O/S missing
|
25,754,556
|
$24,466,828 | — | 22 Nov 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.4%
|
5,804,006
|
$20,836,382 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
5,030,981
|
$18,069,436 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.1%
|
4,575,527
|
$16,426,141 | — | 31 Mar 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
1.1%
|
4,468,830
|
$16,043,100 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
1%
|
4,325,709
|
$15,529,295 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.7%
|
2,926,726
|
$10,506,946 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.63%
|
2,611,133
|
$9,373,967 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.54%
|
2,232,255
|
$8,013,796 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.53%
|
2,214,947
|
$7,951,660 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.52%
|
2,162,212
|
$7,762,341 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.42%
|
1,734,015
|
$6,225,114 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.32%
|
1,328,012
|
$4,767,563 | — | 31 Mar 2025 | |
| Scott J. Leffler |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
4,857,303
|
$4,760,157 | — | 25 Jan 2024 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.31%
|
1,305,200
|
$4,685,668 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.3%
|
1,263,961
|
$4,537,620 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.28%
|
1,174,205
|
$4,215,395 | — | 31 Mar 2025 | |
| Aric R. Sharp |
3/4/5
|
CEO of Value Based Care |
—
class O/S missing
|
2,100,665
|
$3,907,237 | — | 09 Aug 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.25%
|
1,034,223
|
$3,712,861 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.21%
|
886,573
|
$3,182,797 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.21%
|
859,037
|
$3,083,943 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.21%
|
855,264
|
$3,070,398 | — | 31 Mar 2025 | |
| CLOVER HEALTH INVESTMENTS, CORP. /DE |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
3,093,225
|
$3,031,361 | — | 31 Oct 2023 | |
| 8 KNOTS MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
817,905
|
$2,936,279 | — | 31 Mar 2025 | |
| Swiss National Bank |
13F
|
Company |
0.18%
|
758,500
|
$2,723,015 | — | 31 Mar 2025 | |
| Joseph R. Martin |
3/4/5
|
General Counsel |
—
class O/S missing
|
2,718,857
|
$2,664,480 | — | 14 Jun 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.17%
|
706,319
|
$2,535,684 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.16%
|
656,450
|
$2,356,656 | — | 31 Mar 2025 | |
| Verition Fund Management LLC |
13F
|
Company |
0.14%
|
603,942
|
$2,168,152 | — | 31 Mar 2025 | |
| TEACHER RETIREMENT SYSTEM OF TEXAS |
13F
|
Company |
0.14%
|
571,338
|
$2,051,103 | — | 31 Mar 2025 | |
| Chelsea Clinton |
3/4/5
|
Director |
—
class O/S missing
|
602,814
|
$1,983,258 | — | 06 Jan 2025 | |
| Lee Shapiro |
3/4/5
|
Director |
—
class O/S missing
|
598,622
|
$1,969,466 | — | 06 Jan 2025 | |
| UBS Group AG |
13F
|
Company |
0.13%
|
530,903
|
$1,905,942 | — | 31 Mar 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.12%
|
492,725
|
$1,768,883 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.11%
|
447,653
|
$1,607,074 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.11%
|
446,154
|
$1,601,693 | — | 31 Mar 2025 | |
| CAXTON ASSOCIATES LLP |
13F
|
Company |
0.11%
|
445,512
|
$1,599,388 | — | 31 Mar 2025 | |
| Jain Global LLC |
13F
|
Company |
0.1%
|
403,449
|
$1,448,382 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.09%
|
395,369
|
$1,419,375 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.09%
|
387,634
|
$1,391,000 | — | 31 Mar 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.09%
|
375,336
|
$1,347,456 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.09%
|
370,744
|
$1,330,971 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.09%
|
363,309
|
$1,304,280 | — | 31 Mar 2025 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.08%
|
351,446
|
$1,261,691 | — | 31 Mar 2025 | |
| Nathaniel S. Turner |
3/4/5
|
Director |
—
class O/S missing
|
1,324,728
|
$1,258,492 | — | 07 Jan 2021 | |
| OP Asset Management Ltd |
13F
|
Company |
0.08%
|
318,334
|
$1,142,819 | — | 31 Mar 2025 |
Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q2 2025
As of 30 Jun 2025,
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by
197 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
146,128,655 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, PNC Financial Services Group, Inc., BANK OF AMERICA CORP /DE/, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, CITADEL ADVISORS LLC, and MARSHALL WACE, LLP.
This page lists
198
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
197
Q2 2025 holders
197
Holder diff
0
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.